OncoMed Pharmaceuticals (OncoMed Pharmaceuticals) EV-to-FCF : -0.76 (As of May. 05, 2024)

OncoMed Pharmaceuticals EV-to-FCF Chart

OncoMed Pharmaceuticals Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
EV-to-FCF		Get a 7-Day Free Trial				-4.84	-6.82	-2.67	-0.63	0.62

OncoMed Pharmaceuticals Quarterly Data
	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OncoMed Pharmaceuticals's EV-to-FCF

For the Biotechnology subindustry, OncoMed Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoMed Pharmaceuticals's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoMed Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where OncoMed Pharmaceuticals's EV-to-FCF falls into.

OncoMed Pharmaceuticals EV-to-FCF Calculation

OncoMed Pharmaceuticals's EV-to-FCF for today is calculated as:

OncoMed Pharmaceuticals's current Enterprise Value is $34.43 Mil.
OncoMed Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-45.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoMed Pharmaceuticals  (NAS:OMED) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

OncoMed Pharmaceuticals's PE Ratio for today is calculated as:

OncoMed Pharmaceuticals's share price for today is $0.89.
OncoMed Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.210.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

OncoMed Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of OncoMed Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoMed Pharmaceuticals (OncoMed Pharmaceuticals) Business Description